StevenEShoelsonMD
Endocrinology • Boston, MADiabetes, Lipid Metabolism
Professor of Medicine, Joslin Diabetes Center
Dr. Shoelson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1 Joslin Pl
Joslin Diabetes Center
Boston, MA 02215Phone+1 617-732-2528
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1988 - 1989
Brigham and Women's HospitalResidency, Internal Medicine, 1985 - 1988
University of Chicago Division of the Biological Sciences The Pritzker School of MedicineClass of 1985
Certifications & Licensure
MA State Medical License 1989 - 2021
Clinical Trials
- Effect of Salicylate on Glucose Metabolism in Insulin Resistance States Start of enrollment: 2000 Jan 01
- Targeting Inflammation Using Salsalate in CardioVascular Disease Start of enrollment: 2008 Sep 01
- Targeting Inflammation Using Salsalate for Type 2 Diabetes-Stage II Start of enrollment: 2008 Nov 01
Publications & Presentations
PubMed
- 2182 citationsSH2 domains recognize specific phosphopeptide sequencesSongyang Zhou, Steven E. Shoelson, Manas Chaudhuri, Gerald D. Gish, Tony Pawson
Cell. 1993-03-12 - 767 citationsSpecific motifs recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and Vav.Zhou Songyang, Steven E. Shoelson, J McGlade, P Olivier, Tony Pawson
Molecular and Cellular Biology. 1994-04-01 - 779 citationsIdentification of SOCS-3 as a Potential Mediator of Central Leptin ResistanceChristian Bjørbæk, Joel K. Elmquist, J. Daniel Frantz, Steven E. Shoelson, Jeffrey S. Flier
Molecular Cell. 1998-03-01
Press Mentions
Natural Killer Cells Help to Drive Inflammation, Insulin ResistanceMarch 31st, 2016
Health News - Joslin Scientists Find That Salsalate Lowers Blood Glucose in Type 2 DiabetesJuly 4th, 2013
Joslin Scientists Find That Salsalate Lowers Blood Glucose in Type 2 DiabetesJuly 2nd, 2013
Grant Support
- Nf-Kb, Inflammation And Vascular RemodelingNational Heart, Lung, And Blood Institute2006–2011
- Mechanism-Based Biomarkers For Glucose-Lowering In Tinsal-T2dNational Institute Of Diabetes And Digestive And Kidney Diseases2010
- Mediators And Modifiers Of Nf-Kappab In Insulin ResistanceNational Institute Of Diabetes And Digestive And Kidney Diseases2007–2010
- Toll Receptor Activation Of Nf-Kb In Insulin Resistance And T2dmNational Institute Of Diabetes And Digestive And Kidney Diseases2006–2010
- Targeting Inflammation In Type 2 Diabetes: Clinical Trial Using SalsalateNational Institute Of Diabetes And Digestive And Kidney Diseases2006–2010
- Effects Of Ikkb And NFKB In Insulin ResistanceNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2009
- Ser/Thr Phosphorylation In Insulin ResistanceNational Institute Of Diabetes And Digestive And Kidney Diseases2004–2008
- Mediators And Modifiers Of Nf-Kb In Insulin ResistanceNational Institute Of Diabetes And Digestive And Kidney Diseases2005–2006
- Effect Of Salicylate On Glucose Metabolism In Insulin Resistance StatesNational Center For Research Resources2004–2006
- Effect Of Salicylate On Glucose Metabolism In Insulin Resistant StatesNational Center For Research Resources2005
- Salicylate On Glucose Metabolism In Insulin Resistant STNational Center For Research Resources2004
- Potential Cause &Molecular Target Of Insulin ResistancNational Institute Of Diabetes And Digestive And Kidney Diseases2001–2004
- IKK Mediated Insulin Resistance And In Vivo ReversalNational Institute Of Diabetes And Digestive And Kidney Diseases2000–2004
- Structure Of IRS Proteins In Insulin ResistanceNational Institute Of Diabetes And Digestive And Kidney Diseases1998–2002
- Core--Peptide Biochemistry FacilityNational Institute Of Diabetes And Digestive And Kidney Diseases1997–2001
- Receptor/Substrate Complexes In Transmembrane SignalingNational Institute Of Diabetes And Digestive And Kidney Diseases1996–1999
- New SH2 Proteins In Insulin ActionNational Institute Of Diabetes And Digestive And Kidney Diseases1996–1998
- Mapping The Insulin-Receptor InterfaceNational Institute Of Diabetes And Digestive And Kidney Diseases1992–1996
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
